Allison E. Drew

949 citations

22 papers · 661 indexed · h-index 11

Impact in

Molecular Biology
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Chromatin Remodeling and Cancer
- Nicotinic Acetylcholine Receptors Study
Ecology, Evolution, Behavior and Systematics top 10%
- Plant and animal studies

Papers in ⓘ

Insect Science 4
- Insect-Plant Interactions and Control 3
Cellular and Molecular Neuroscience 4

Co-authors: Linda L. Werling (4 shared papers)Charles F. Williams (1 shared paper)Scott Ribich (7 shared papers)Robert A. Copeland (4 shared papers)J. Joshua Smith (5 shared papers)Richard Chesworth (3 shared papers)Melissa J. Merrick (2 shared papers)Rosemary J. Smith (2 shared papers)
Journals: Cancer Research (5 papers)Environmental Entomology (4 papers)Molecular Cancer Therapeutics (3 papers)ACS Medicinal Chemistry Letters (1 paper)SLAS DISCOVERY (1 paper)
Partner nations: United States

In The Last Decade

Allison E. Drew

22 papers receiving 636 citations

Peers

Countries citing papers authored by Allison E. Drew

Since Specialization

Citations

This map shows the geographic impact of Allison E. Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison E. Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison E. Drew more than expected).

Fields of papers citing papers by Allison E. Drew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison E. Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison E. Drew. The network helps show where Allison E. Drew may publish in the future.

Co-authors

The 25 scholars most cited alongside Allison E. Drew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Allison E. Drew Line = papers co-authored together Allison E. Drew links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models Molecular Cancer Therapeutics ·Elayne Chan-Penebre, Kelli Armstrong, Allison E. Drew, Alexandra Grassian, Igor Feldman, Sarah K. Knutson, Kristy Kuplast‐Barr, Maria Roche, John Campbell, Peter Ho, Robert A. Copeland, Richard Chesworth, J. Joshua Smith, Heike Keilhack, Scott Ribich	2017	127
2	Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound ACS Medicinal Chemistry Letters ·Lorna H. Mitchell, Allison E. Drew, Scott Ribich, Nathalie Rioux, Kerren K. Swinger, Suzanne L. Jacques, Trupti Lingaraj, P. Ann Boriack‐Sjodin, Nigel J. Waters, Tim J. Wigle, Oscar Moradei, Lei Jin, Thomas V. Riera, Margaret Porter-Scott, Mikel P. Moyer, J. Joshua Smith, Richard Chesworth, Robert A. Copeland	2015	95
3	Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex Synapse ·Allison E. Drew, Alicia E. Derbez, Linda L. Werling	2000	73
4	Floral dimorphism, pollination, and self‐fertilization in gynodioecious GERANIUM RICHARDSONII (Geraniaceae) American Journal of Botany ·Charles F. Williams, Margaret A. Kuchenreuther, Allison E. Drew	2000	73
5	EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL Molecular Cancer Therapeutics ·Dorothy Brach, Danielle Johnston-Blackwell, Allison E. Drew, Trupti Lingaraj, Vinny Motwani, Natalie M. Warholic, Igor Feldman, Christopher Plescia, J. Joshua Smith, Robert A. Copeland, Heike Keilhack, Elayne Chan-Penebre, Sarah K. Knutson, Scott Ribich, Alejandra Raimondi, Michael J. Thomenius	2017	52
6	Altitudinal Variation in Body Size and Population Density of <I>Nicrophorus investigator</I> (Coleoptera: Silphidae) Environmental Entomology ·Rosemary J. Smith, Amy Hines, Stephanie Richmond, Melissa J. Merrick, Allison E. Drew, Rachelle Fargo	2000	44
7	The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer Journal of Medicinal Chemistry ·Richard T. Lewis, Christiane Bode, Deborah M. Choquette, Michele Potashman, Karina Romero, John Stellwagen, Yohannes Teffera, Earl Moore, Douglas A. Whittington, Hao Chen, Linda F. Epstein, Renee Emkey, Paul S. Andrews, Violeta Yu, Douglas C. Saffran, Man Xu, Allison E. Drew, Patricia Merkel, Steven Szilvassy, Rachael Brake	2012	38
8	Altitudinal Variation in Body Size and Population Density ofNicrophorus investigator(Coleoptera: Silphidae) Environmental Entomology ·Rosemary J. Smith, Amy Hines, Stephanie Richmond, Melissa J. Merrick, Allison E. Drew, Rachelle Fargo	2000	36
9	Structural Insights into Ternary Complex Formation of Human CARM1 with Various Substrates ACS Chemical Biology ·P. Ann Boriack‐Sjodin, Lei Jin, Suzanne L. Jacques, Allison E. Drew, Chris Sneeringer, Margaret Porter Scott, Mikel P. Moyer, Scott Ribich, Oscar Moradei, Robert A. Copeland	2015	32
10	Protein kinase C regulation of dopamine transporter initiated by nicotinic receptor activation in slices of rat prefrontal cortex Journal of Neurochemistry ·Allison E. Drew, Linda L. Werling	2001	22
11	Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine Schizophrenia Research ·Allison E. Drew, Linda L. Werling	2003	20
12	Abstract 1795: Characterization of a novel series of potent, selective inhibitors of wild type and mutant/fusion anaplastic lymphoma kinase Cancer Research ·Keith Wilcoxen, Rachael Brake, Doug Saffran, Yohannes Teffera, Deborah M. Choquette, Doug Whittington, Violeta Yu, Karina Romero, Christiane Bode, John Stellwagen, Michelle Potashman, Renee Emkey, Paul S. Andrews, Allison E. Drew, Man Xu, Stephen J. Szilvassy, Samer Al-Assad, Richard T. Lewis	2012	10
13	Insect Biodiversity on Plant Hybrids Within the Hawaiian Silversword Alliance (Asteraceae: Heliantheae-Madiinae) Environmental Entomology ·Allison E. Drew, George Roderick	2005	8
14	Insect Biodiversity on Plant Hybrids Within the Hawaiian Silversword Alliance (Asteraceae: Heliantheae-Madiinae) Environmental Entomology ·Allison E. Drew, George Roderick	2005	8
15	Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and Development of an ALK Inhibitor SLAS DISCOVERY ·Allison E. Drew, Samer Al-Assaad, Violeta Yu, Paul S. Andrews, Patricia Merkel, Stephen J. Szilvassy, Renee Emkey, Richard Lewis, Rachael Brake	2011	5
16	Nicotinic receptor‐mediated regulation of dopamine transporter activity in rat prefrontal cortex Synapse ·Allison E. Drew, Alicia E. Derbez, Linda L. Werling	2000	4
17	Phosphatidylinositol-3 Kinase Delta (PI3Kδ) Inhibitor AMG 319 Is a Potent, Selective and Orally Bioavailable Small Molecule Inhibitor That Suppresses PI3K-Mediated Signaling and Viability in Neoplastic B Cells Blood ·Angus M. Sinclair, Daniela Metz, Tim Cushing, Liqin Liu, Rachael Brake, Charlie Starnes, Gary Means, Kirk R. Henne, Ivonne Archibeque, Bethany Mattson, Allison E. Drew, Leigh Busse, Ling Wang, Ali-Samer Al-Assaad, Graham Molineux	2011	4
18	Abstract C87: EZH2 inhibition leads to decreased proliferation in SMARCA4-deleted ovarian cancer cell lines Molecular Cancer Therapeutics ·Sarah K. Knutson, Allison E. Drew, Christopher Plescia, Robert A. Copeland, J. Joshua Smith, Heike Keilhack, Scott Ribich	2015	3
19	Abstract 5060: Activity of the EZH2 inhibitor tazemetostat as a monotherapy and in combination with multiple myeloma therapies in preclinical models Cancer Research ·Allison E. Drew, Vinny Motwani, John E. Campbell, Cuyue Tang, J. Joshua Smith, Richard Chesworth, Robert A. Copeland, Alejandra Raimondi, Scott Ribich	2017	3
20	Abstract 808: Opportunity for therapeutic expansion in mantle cell lymphoma: Tazemetostat combination synergy status in preclinical MCL models Cancer Research ·Tami Hood, Kat Cosmopoulos, Allison E. Drew, Kelli Armstrong, Jennifer E. Johnson, Smith Jesse, Alejandra Raimondi	2018	2

About Allison E. Drew

Allison E. Drew is a scholar working on Insect Science, Cellular and Molecular Neuroscience, Molecular Biology, Ecology, Evolution, Behavior and Systematics and Pathology and Forensic Medicine, having authored 22 papers that have together received 661 indexed citations. Recurring topics across this work include Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (5 papers), Lung Cancer Treatments and Mutations (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Plant and animal studies (3 papers), RNA modifications and cancer (3 papers), Insect-Plant Interactions and Control (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Molecular Biology (444 citations), Ecology, Evolution, Behavior and Systematics (111 citations), Nature and Landscape Conservation (68 citations), Pathology and Forensic Medicine (94 citations) and Insect Science (55 citations). Allison E. Drew has collaborated with scholars based in United States. Frequent co-authors include Linda L. Werling, Charles F. Williams, Scott Ribich, Robert A. Copeland, J. Joshua Smith, Richard Chesworth, Melissa J. Merrick, Rosemary J. Smith, Heike Keilhack and Sarah K. Knutson. Their work appears in journals such as Cancer Research, Environmental Entomology, Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact